Abstract:We used a recently developed test of spatial memory--the Four Mountains Test--to investigate the core cognitive processes underpinning topographical disorientation in patients with amnestic mild cognitive impairment (a-MCI) and mild Alzheimer's disease (AD). Performance of these clinical groups was compared with age-matched controls, patients with frontotemporal lobar degeneration (FTLD), and patients with subjective memory impairments. We investigated the perception (concurrent match-to-sample) and short-term… Show more
“…2 B). The form of learning impairment presented here is consistent with other studies' results showing intact topographical perception in AD (Bird et al, 2010) and partially preserved route learning capacities in virtual reality in early AD (Cushman et al, 2008).…”
“…This hippocampal locus of early AD pathology is consistent with spatiotemporal orientation impairments in everyday activities (Pai and Jacobs, 2004), such as difficulties in finding one's way in unfamiliar environments in both patients with prodromal AD-the symptomatic predementia phase (deIpolyi et al, 2007;Cushman et al, 2008)-and AD patients (Bird et al, 2010). Correspondingly, patients with mild AD are impaired for spatial memory (Kessels et al, 2005;Hort et al, 2007;Cushman et al, 2008) as well as for spatiotemporal memory (Cherrier et al, 2001;Kalová et al, 2005;deIpolyi et al, 2007).…”
Episodic memory impairment is a hallmark for early diagnosis of Alzheimer's disease. Most actual tests used to diagnose Alzheimer's disease do not assess the spatiotemporal properties of episodic memory and lead to false-positive or -negative diagnosis. We used a newly developed, nonverbal navigation test for Human, based on the objective experimental testing of a spatiotemporal experience, to differentially Alzheimer's disease at the mild stage (N ϭ 16 patients) from frontotemporal lobar degeneration (N ϭ 11 patients) and normal aging (N ϭ 24 subjects). Comparing navigation parameters and standard neuropsychological tests, temporal order memory appeared to have the highest predictive power for mild Alzheimer's disease diagnosis versus frontotemporal lobar degeneration and normal aging. This test was also nonredundant with classical neuropsychological tests. As a conclusion, our results suggest that temporal order memory tested in a spatial navigation task may provide a selective behavioral marker of Alzheimer's disease.
“…2 B). The form of learning impairment presented here is consistent with other studies' results showing intact topographical perception in AD (Bird et al, 2010) and partially preserved route learning capacities in virtual reality in early AD (Cushman et al, 2008).…”
“…This hippocampal locus of early AD pathology is consistent with spatiotemporal orientation impairments in everyday activities (Pai and Jacobs, 2004), such as difficulties in finding one's way in unfamiliar environments in both patients with prodromal AD-the symptomatic predementia phase (deIpolyi et al, 2007;Cushman et al, 2008)-and AD patients (Bird et al, 2010). Correspondingly, patients with mild AD are impaired for spatial memory (Kessels et al, 2005;Hort et al, 2007;Cushman et al, 2008) as well as for spatiotemporal memory (Cherrier et al, 2001;Kalová et al, 2005;deIpolyi et al, 2007).…”
Episodic memory impairment is a hallmark for early diagnosis of Alzheimer's disease. Most actual tests used to diagnose Alzheimer's disease do not assess the spatiotemporal properties of episodic memory and lead to false-positive or -negative diagnosis. We used a newly developed, nonverbal navigation test for Human, based on the objective experimental testing of a spatiotemporal experience, to differentially Alzheimer's disease at the mild stage (N ϭ 16 patients) from frontotemporal lobar degeneration (N ϭ 11 patients) and normal aging (N ϭ 24 subjects). Comparing navigation parameters and standard neuropsychological tests, temporal order memory appeared to have the highest predictive power for mild Alzheimer's disease diagnosis versus frontotemporal lobar degeneration and normal aging. This test was also nonredundant with classical neuropsychological tests. As a conclusion, our results suggest that temporal order memory tested in a spatial navigation task may provide a selective behavioral marker of Alzheimer's disease.
“…Correlations were not determined for other brain regions, reflecting the study hypothesis. In particular, correlations with frontal brain regions were not calculated since 4MT performance is not impaired in patients with frontotemporal dementia 18,19 . All study groups (MCI, AD, HC), and within the MCI biomarker subgroups, were matched in terms of demographics (age, gender, years of education) ( Table 1 20 .…”
Section: Representative Resultsmentioning
confidence: 99%
“…There were significant differences between study groups in terms of performance on the 4MT test (p <0.001, 18,19 , 4MT scores differed significantly between groups of MCI patients with and without CSF biomarker evidence of AD, who were otherwise matched in terms of demographics, symptom duration, premorbid IQ and performance on general neuropsychometric testing. Of particular note, there was no significant difference between the 2 MCI groups in terms of Rey Auditory Verbal Learning Test (RAVLT) performance.…”
Section: Mt Performancementioning
confidence: 92%
“…The aim of the viewpoint change is to encourage allocentric spatial strategies (exploiting spatial representations which are known to exist within the hippocampal formation, see Hartley et al, 2014 for a recent review , this test was applied to patients with dementia. Results from separate research groups showed that the 4MT could differentiate patients with ADrelated dementia, not only from age-matched control subjects but also from patients with other dementia-causing disorders 18,19 .…”
This protocol describes the administration of the 4 Mountains Test (4MT), a short test of spatial memory, in which memory for the topographical layout of four mountains within a computer-generated landscape is tested using a delayed match-to-sample paradigm. Allocentric spatial memory is assessed by altering the viewpoint, colors and textures between the initially presented and target images.Allocentric spatial memory is a key function of the hippocampus, one of the earliest brain regions to be affected in Alzheimer's disease (AD) and impairment of hippocampal function predates the onset of dementia. It was hypothesized that performance on the 4MT would aid the diagnosis of predementia AD, which manifests clinically as Mild Cognitive Impairment (MCI).The 4MT was applied to patients with MCI, stratified further based on cerebrospinal fluid (CSF) AD biomarker status (10 MCI biomarker positive, 9 MCI biomarker negative), and with mild AD dementia, as well as healthy controls. Comparator tests included tests of episodic memory and attention widely accepted as sensitive measures of early AD. Behavioral data were correlated with quantitative MRI measures of the hippocampus, precuneus and posterior cingulate gyrus.4MT scores were significantly different between the two MCI groups (p = 0.001), with a test score of ≤8/15 associated with 100% sensitivity and 78% specificity for the classification of MCI with positive AD biomarkers, i.e., predementia AD. 4MT test scores correlated with hippocampal volume (r = 0.42) and cortical thickness of the precuneus (r = 0.55).In conclusion, the 4MT is effective in identifying the early stages of AD. The short duration, easy application and scoring, and favorable psychometric properties of the 4MT fulfil the need for a simple but accurate diagnostic test for predementia AD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.